The efficacy of cognitive behavioral therapy-based intervention on patients with diabetes: A meta-analysis

Yanni Li; Eric A Storch; Samantha Ferguson; Li Li; Nicholas Buys; Jing Sun

doi:10.1016/j.diabres.2022.109965

The efficacy of cognitive behavioral therapy-based intervention on patients with diabetes: A meta-analysis

Diabetes Res Clin Pract. 2022 Jul:189:109965. doi: 10.1016/j.diabres.2022.109965. Epub 2022 Jun 16.

Authors

Yanni Li¹, Eric A Storch², Samantha Ferguson¹, Li Li³, Nicholas Buys⁴, Jing Sun⁵

Affiliations

¹ School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland Q422, Australia.
² Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX 77030, USA.
³ Department of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, Zhejiang Province 315010, China.
⁴ Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland Q422, Australia.
⁵ School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland Q422, Australia; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland Q422, Australia. Electronic address: j.sun@griffith.edu.au.

PMID: 35718018
DOI: 10.1016/j.diabres.2022.109965

Abstract

Aims: This meta-analysis aims to update former meta-analyses from randomized controlled trials (RCT) focused on the efficacy of CBT for diabetes.

Methods: Five databases were searched for RCTs. Primary outcomes were glycated hemoglobin (HbA_1c), fasting blood glucose (FBS), systolic blood pressure (SBP), diastolic blood pressure (DBP), and body mass index (BMI). Secondary outcomes were depression, anxiety and distress symptoms, quality of life, sleep quality.

Results: 32 RCTs were included. Results revealed that CBT could reduce HbA_1c: -0.14% (95% CI: -0.25 to -0.02%, P = 0.020); FBS: -15.48 mg/dl (95% CI: -30.16 to -0.81 mg/dl, P = 0.040); DBP: -2.88 mmHg (95% CI: -4.08 to -1.69 mmHg, P < 0.001); depression symptoms: -0.90 (95% CI: -1.22 to -0.57, P < 0.001); anxiety symptoms: -0.28 (95% CI: -0.50 to -0.07, P = 0.009); improve sleep quality: -0.92 (95% CI: -1.77 to -0.07, P = 0.030). Subgroup analysis indicated that CBT has siginificantly reduced HbA_1c when delivered as a group-based and face-to-face method, and psycho-education, behavioral, cognitive, goal-setting, homework assignment strategies were applied as central strategies.

Conclusion: CBT was an effective treatment for diabetes patients, significantly reduced their HbA_1c, FBS, DBP, depression and anxiety symptoms, and improved sleep quality.

Keywords: Cognitive behavioral therapy; Diabetes; Physiological factors; Psychological factors; Quality of life.

Publication types

Meta-Analysis
Review

MeSH terms

Anxiety / therapy
Anxiety Disorders
Cognitive Behavioral Therapy* / methods
Diabetes Mellitus* / therapy
Humans
Quality of Life